Back to Search Start Over

Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia.

Authors :
Miglani, Manjula
Pasha, Qadar
Gupta, Archana
Priyadarshini, Anjali
Pati Pandey, Ramendra
Vibhuti, Arpana
Source :
Drug Discovery Today. Nov2021, Vol. 26 Issue 11, p2774-2781. 8p.
Publication Year :
2021

Abstract

[Display omitted] • Hypobaric hypoxia at high altitude is responsible for AMS, HAPE and HACE. • ROS due to oxidative stress, along with UV rays at HA may lead to telomeric damage. • Oxidative stress inhibits telomerase activity and promote telomere erosion. • Telomeric TNKS play protective roles during telomeric damage by increasing its activity. • Tankyrase are involved in various physiological events of body. Cellular exposure to extreme environments leads to the expression of multiple proteins that participate in pathophysiological manifestations. Hypobaric hypoxia at high altitude (HA) generates reactive oxygen species (ROS) that can damage telomeres. Tankyrase (TNKS) belongs to multiple telomeric protein complexes and is actively involved in DNA damage repair. Although published research on TNKS indicates its possible role in cancer and other hypoxic diseases, its role in HA sicknesses remains elusive. Understanding the roles of telomeres, telomerase, and TNKS could ameliorate physiological issues experienced at HA. In addition, telomeric TNKS could be a potential biomarker in hypoxia-induced sicknesses or acclimatization. Thus, a new research avenue on TNKS linked to HA sickness might lead to the discovery of drugs for hypobaric hypoxia. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13596446
Volume :
26
Issue :
11
Database :
Academic Search Index
Journal :
Drug Discovery Today
Publication Type :
Academic Journal
Accession number :
153681324
Full Text :
https://doi.org/10.1016/j.drudis.2021.07.012